Outcomes after Adjuvant Therapy in High-Intermediate and High-risk Early-stage Uterine Carcinoma

被引：0
|
作者：
Tatebe, K. [1 ]
Hasan, Y. [1 ]
Son, C. H. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1775
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_21_3527
引用
下载
收藏
页码：E654 / E654
页数：1
相关论文
共 50 条
  • [1] Outcomes after chemotherapy, radiation or combination therapy for high-intermediate and high-risk early-stage endometrial cancer
    Nieto, V. L.
    Wright, J. D.
    Chen, L.
    Hou, J. Y.
    Tergas, A. I.
    Collado, F. Khoury
    St Clair, C. M.
    Melamed, A.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 206 - 206
  • [2] Cost-Effectiveness of Adjuvant Intravaginal Brachytherapy in High-Intermediate Risk Early Stage Endometrial Carcinoma
    Stahl, J. M.
    Lester-Coll, N. H.
    Bledsoe, T. J.
    An, Y.
    Damast, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E416 - E416
  • [3] Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma
    Min Wu
    Ya-nan Yang
    Yu-hui Huang
    Jing Cai
    Xiao-qi He
    Ze-hua Wang
    Current Medical Science, 2022, 42 : 185 - 191
  • [4] Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma
    Wu, Min
    Yang, Ya-nan
    Huang, Yu-hui
    Cai, Jing
    He, Xiao-qi
    Wang, Ze-hua
    CURRENT MEDICAL SCIENCE, 2022, 42 (01) : 185 - 191
  • [5] Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
    Philp, Lauren
    Tannenbaum, Sora
    Haber, Hilary
    Saini, Aashna
    Laurent, Jessica St.
    James, Kaitlyn
    Feltmate, Colleen
    Russo, Andrea
    Growdon, Whitfield
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S146 - S146
  • [6] Adjuvant Vaginal Brachytherapy and Chemotherapy in the Management of High-Intermediate Risk Early-stage Endometrial Cancer: A Single Institutional Report
    Iglesias, A. J.
    Wolfson, A. H.
    Portelance, L.
    Zhao, W.
    Stine, J.
    Yali, P.
    Lucci, J.
    Schuman, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S476 - S476
  • [7] Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
    Philp, L.
    Tannenbaum, S.
    Haber, H.
    Saini, A.
    St Laurent, J.
    James, K.
    Feltmate, C. M.
    Russo, A. L.
    Growdon, W. B.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (02) : 389 - 395
  • [8] Efficacy of Therapy vs Surveillance in Patients with Resected Early-Stage Intermediate to High-Risk Renal Cell Carcinoma
    Major, C. Kendall
    Rodriguez, Carlos I.
    Haas, Naomi B.
    KIDNEY CANCER, 2023, 7 (01) : 19 - 35
  • [9] Optimal adjuvant therapy and outcomes for early-stage uterine serous and clear cell carcinoma
    McEachron, Jennifer
    Zhou, Nancy
    Bennett, Michelle
    Hastings, Victoria
    Kanis, Margaux
    Gorelick, Constantine
    Lee, Yi-Chun
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S221 - S221
  • [10] Impact of adjuvant therapy on oncologic outcomes in early-stage uterine clear cell carcinoma
    Nobre, S. Pedra
    Ataseven, B.
    Bois, A. D.
    Makker, V.
    Alektiar, K.
    Leitao, M. M., Jr.
    Abu-Rustum, N. R.
    Mueller, J. J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 325 - 325
12345